KEQUNasdaqLaboratory Apparatus & FurnitureFiscal year ends April 30
KEWAUNEE SCIENTIFIC CORP /DE/
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$32.10−0.82 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $93.76M
- P/E (TTM)
- 11.6
- Dividend yield
- –
KEWAUNEE SCIENTIFIC CORP /DE/ revenue by segment
By business segment
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Operations | – | – | $71.73M | $68.47M | $64.96M | $61.07M | $60.26M | $60.07M | $64.97M | $66.52M | $64.54M | $74.22M | – | – |
| Domestic Operations | – | – | $216.02M | $217.04M | $198.23M | $179.40M | $159.77M | $139.57M | $137.34M | $137.24M | $136.50M | $140.86M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Kewaunee Scientific's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.